Medicare launches pilot program expanding access to GLP-1 drugs
The program's demonstration run will last from July 1, 2026, until December 31, 2027, Medicare said.
Original Source
Read the full article at Newsnationnow →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.